You will likely be asked "Should I get the COVID-19 vaccine?" by patients, family and friends.

Students play a very important role in the COVID-19 vaccination campaign. As community ambassadors and vaccine providers, you will need to know the evidence and be prepared to address common questions. Your engagement will help promote widespread vaccination.

This module contains a brief summary of select current available information about the vaccines and links to key documents and resources for you to be able to answer common questions about the vaccines.

Learning objectives:

By the end of this module learners will be able to:

Access key resources for information about the COVID-19 vaccines.
Summarize key points about the COVID-19 vaccines.
Use the information to help answer questions about vaccine efficacy, safety and dosing.

COVID Vaccine Cartoon

Image Source: Alexandra Koch Pixabay

There are seven vaccines currently approved for use in Canada.

Manufacturer	Trade name (generic drug name)	Vaccine type
Pfizer BioNTech	Comirnaty^TM(tozinameran)	mRNA
Moderna	Spikevax^TM(elasomeran)	mRNA
Moderna	Spikevax^TMBivalent (original/omicron)	mRNA
AstraZeneca	Vaxzevria^TM	viral vector
Verity Pharmaceutical (in conjunction with AstraZeneca	COVISHIELD	viral vector
Janssen	Janssen COVID-19 vaccine	viral vector
Novavax	Nuvaxovid^TM	Protein subunit vaccine
Medicago	Covifenz(R)	Virus-like particle vaccine

In the pages that follow, we extract some key components to highlight relevant sections. The full product monograph for each vaccine can be found by searching the Health Canada Drug Product Database. (Links to an external site.)

Module A: Page 1 of 9